TipRanks
55% OFF
PC:AST1B

Astrocyte Pharmaceuticals Inc

A clinical-stage biotechnology company developing cerebroprotective therapies for concussion, traumatic brain injury, and stroke. Its lead program, AST-004, is being evaluated in Phase 2 clinical development, including a trial for sports-related concussion.

Leadership & Board

Latest Estimated Valuation

Estimated Valuation
―
Total Amount Raised
$10M
Total Funding Rounds
1
Latest Funding Amount
$10M
Latest Funding Round
Series B
Post-Money Valuation
―

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Sep 30, 2026Series B$9.50M―

Similar Companies

A snapshot of private companies similar to Astrocyte Pharmaceuticals Inc, helping you discover and navigate related company profiles.

Related News and Analysis